ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Mersana Therapeutics Inc

Mersana Therapeutics Inc (MRSN)

2.53
0.21
(9.05%)
Closed 09 December 8:00AM
2.5288
-0.0012
(-0.05%)
After Hours: 10:55AM

Mersana Therapeutics Inc Financial Summary

The current MRSN market cap is 312.39M. The company's latest EPS is USD -1.3897 and P/E is -1.81.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 10.65M7.7M10.7M9.25M2.29M
Operating Income -56.5M-43.94M-21.43M-21M-25.46M
Net Income -54.31M-41.66M-19.54M-19.31M-24.27M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 42.12M828k43k26.58M36.86M
Operating Income -30.2M-88.11M-168.86M-203.77M-179.67M
Net Income -28.21M-88.05M-170.06M-204.21M-171.67M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 311M262.9M226.06M198.37M179.13M
Total Liabilities 221.2M210.71M189.16M170.39M170.7M
Total Equity 89.8M52.2M36.9M27.99M8.43M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 107.54M273.4M206.11M334.34M226.06M
Total Liabilities 29.22M45.31M84.37M242.28M189.16M
Total Equity 78.32M228.09M121.74M92.06M36.9M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -90.84M-136.92M-168.88M-32.66M-63.11M
Investing -4.04M99.74M119.88M-72.55M-67.03M
Financing 94.73M94.58M94.68M5.83M6.24M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -67.74M-74.7M-139.99M-49.36M-168.88M
Investing -27.29M37.03M-648k-152.72M119.88M
Financing 97.7M230.41M63.65M153.02M94.68M
Market Cap 312.39M
Price to Earnings Ratio -1.81
Price to Sales Ratio 8.45
Price to Cash Ratio 1.78
Price to Book Ratio 8.44
Dividend Yield -

Share Statistics

Shares Outstanding 123.53M
Average Volume (1 week) 775.46k
Average Volume (1 Month) 1.34M
52 Week Change 14.95%
52 Week High 6.2801
52 Week Low 1.22
Spread (Intraday) 1.54 (38.5%)

Company Info

Company Name Mersana Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.mersana.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock